SPECIAL STORY
Karnataka
Hails CSR in
Healthcare
COVER STORY
OUT
NOW!
INTRODUCING
HDL3-C
HDL3-C (High Density Lipoprotein 3 Several lines of evidence suggest that The need for a more extensive lipid
Cholesterol) is a smaller, more dense measuring HDL3-C better reflects CHD profiling is on the increase, to truly
subfraction of the HDL par ticle. risk than measurement of total HDL, identify the risk of disease and provide
making it an additional tool for better risk the necessary tools to prevent and
profiling. reduce the risks.
Randox HDL3 is for research use only and not for use in diagnostic procedures.
ASIA’S FIRST MONTHLY MAGAZINE ON THE ENTERPRISE OF HEALTHCARE
4 MARCH / 2017
ehealth.eletsonline.com
FEBRUARY / 2017
ehealth.eletsonline.com 5
Contents MARCH 2017 | VOLUME - 12 | ISSUE - 03
12
Cover Story
Exploring a New Horizon
of Growth
With a view to bring in the highest degree of professionalism
in regulation of medical devices, a culture of self-compliance
by manufacturers and push the industry’s growth to new
heights, the government has initiated several important
reformatory steps.
14
Special Story
24
Industry Perspective
Fostering Medtech
Innovations in India
Having evolved significantly in the last decade, the Indian medtech
industry is witnessing a high growth trajectory. The recent policy
changes initiated by the government to create a predictable and
enabling ecosystem are expected to set the ball rolling to make
India a powerhouse in manufacturing of medical devices.
6 MARCH / 2017
ehealth.eletsonline.com
Powered By Supported By
Conference Overview
eHEALTH Pharma CIO Symposium 2017 will take place in Mumbai on 21st April 2017.
eHealth Pharma CIO Symposium will be an ideal platform for organisations to meet, deliberate, network
and forge strong ties with key attendees who are looking for new age technology solutions
to incorporate within their organisations.
Our Publication
GET INVOLVED
Nilender Kumar | sales@ehealthonline.org | +91-8860635837
cio.eletsonline.com/events/pharma
Company at a Glance Industry Speaks
20 22
Industry Perspective
30 32
36 38 40
34 42 44
8 MARCH / 2017
ehealth.eletsonline.com
MARCH / 2017
ehealth.eletsonline.com 9
Great Push for
Medical Devices Industry
editorial
India took a giant leap in medical devices and equipment sector recently
when the Ministry of Health and Family Welfare notified Medical Devices
Rules, 2017 on January 31. The new rules have been framed not only to
provide a framework for the industry to conform to the best international
practices, but also seek to remove regulatory bottlenecks to make in
India, facilitate ease of doing business while ensuring availability of
better medical devices for patient care and safety.
The cover story, ‘Exploring a New Horizon of Growth’, in eHealth March
issue, is an attempt to provide a comprehensive look at the policy push
offered by the government that is aimed at reducing India’s dependency
on imports of high-end medical devices. The move also seeks to promote
the highest degree of professionalism in the sector, a culture of self-
compliance by manufacturers and fostering India specific innovations
to improve accessibility and affordability of medical devices across the
world.
Our special story ‘Karnataka Hails CSR in Healthcare’ underscores
the state government’s attempt to live up to its motto of ‘Health for all
and Health Everywhere’ through quality healthcare services under its
Corporate Social Responsibility (CSR) initiative. It offers our readers
a sneak peek into the public health programmes of the Karnataka
government and its vision behind taking quality healthcare delivery to
the door steps of the vulnerable sections of the population in remote,
unreached and poorly accessible under-served areas of Karnataka.
In the story, ‘Fostering Medtech Innovations in India,’ Dr Suchita Markan,
Assistant General Manager at BCIL, examines the growth trajectory
of the medtech industry as she highlights how the sector is charged
with new energy in the conducive environment that has been created to
provide a robust and enabling ecosystem for domestic manufacturers
and service providers.
This edition of the eHealth magazine carries interviews of industry
experts from the government as well as private sector, expressing their
views on how new policies, regulations, infrastructure and technology
collaborations are gradually, yet surely, changing the face of health
delivery system in India.
Looking forward to our readers’ valuable feedbacks.
Dr Ravi Gupta
Editor-in-Chief
ravi.gupta@elets.in
10 MARCH / 2017
ehealth.eletsonline.com
MARCH / 2017
ehealth.eletsonline.com 11
Cover Story
Exploring a
New Horizon
of Growth
I
ndia, like several other countries in the world, large- ical devices sector in the country. The new Rules seek to
ly depends on imports to fulfill its medical equipment remove regulatory bottlenecks to make in India, facilitate
needs. Over 75 per cent of high-end medical devices, ease of doing business while ensuring availability of better
critical care equipment are imported, whereas large medical devices for patient care and safety,” said the Min-
volume and comparatively low-end consumables and dis- istry of Health and Family Welfare in a statement.
posables are locally manufactured. The announcement of the government that regulatory
Heeding to the long-standing demand of indigenous framework can be reviewed from time to time based on
manufacturers of medical devices and equipment manu- industry feedback is commendable. The new rules and
facturers, the government recently decided to put in place regulations will help augment indigenous production and
new rules and regulations for medical devices industry, would also bring about qualitative changes in the health-
which was unduly delayed. These new rules seek to in- care landscape and help India achieve universal health-
ternationally harmonise manufacturing of medical devices care faster. In short, the move will be a game-changer for
to attract investment in the sector -- reducing the cost of the medical devices and equipment industry.
making medical devices and equipment in the country. “The move is expected to inculcate discipline. It will en-
“The new Rules have been framed in conformity with able each stakeholder to know what is expected from him
Global Harmonisation Task Force (GHTF) framework and so that he sticks to his role. This has enabled car drivers
conform to best international practices. Only 15 catego- to drive without maximum speed limits in Germany. Simi-
ries of medical devices are, at present, regulated as drugs larly in manufacturing, rules and regulations for medical
and to that extent, the current regulatory practices in In- devices will bring in the discipline to ensure patient safe-
dia were not fully geared to meet the requirements of med- ty and this will enable making of medical devices in India
12 MARCH / 2017
ehealth.eletsonline.com
Cover Story
to grow without any limits,” says Rajiv Nath Forum Co- Internet of Tings (IoT), big data analytics, and artificial
ordinator, Association of Indian Medical Device Industry intelligence are positively impacting the growth of medical
(AiMeD). devices sector and are set to play greater role in years to
Another major step the government has taken is the de- come. However, Rajiv Nath of AiMeD is of the opinion that
cision to soon delink the medical devices and equipment the industry first needs to take one step at a time to reach
industry from the pharma sector “so that it can chart a its goals. “These (IoT, artificial intelligence, etc) are buzz
distinct and definitive course along with a facilitating reg- words and fads. Before you reach the seventh floor, you
ulatory frame work”, according to Minister for Chemicals have to climb the steps to the first floor. Let’s go step by
and Fertilisers Ananth Kumar. step,” he says.
“As the Minister of Chemicals & Fertilizers said, it is Speaking of the roadblocks, Rajiv Nath says that coun-
time for these sector to be delinked and fly like a butter- ter lobbying by foreign manufacturers is a cause of con-
fly. Both pharma and devices are healthcare products and cern. “Counter lobbying by foreign manufacturers is a
have synergies and similar direction, but need different roadblock. They are misusing forums of CII (Confedera-
pathways and strategies as pharmaceutical is an estab- tion of Indian Industry) and FICCI (Federation of Indian
lished sector, while medical devices is a sunrise sector Chambers of Commerce and Industry) for blocking and de-
and has the potential to grow and overtake pharma,” says laying any policy initiative that could help ‘Make in India’
Rajiv Nath. to be competitive since they see these initiatives through
To drive the growth of the industry, the government a short-term tunnel vision as creating loss of competitive
seems quite clear in its vision. “Three areas that we are advantage and threat to their market share instead of uti-
considering now are promoting medical devices park, lising them as a long-term opportunity to invest in Green
R&D and medical value added services like tourism, which Field Projects in India and share our growth pains,” he
can help us to reduce the dependence on imports of medi- says.
cal devices and earn more foreign exchange by promoting India is endowed with a large reservoir of experts in
value added medical services like medical tourism,” said software and other disciplines of information technology,
KL Sharma, Joint Secretary, Ministry of Health & Family which can help India emerge as a powerful hub for man-
Welfare, recently at a government-supported event. ufacturing of medical equipment. In this regard, medical
So far as leveraging technological innovations is con- technology clusters coming up in Andhra Pradesh and Tel-
cerned, there is the need for more concrete partnership angana are steps in the right direction. Apart from incen-
between the government and the private sector in the tivising the medical device industry, it is necessary to set
medical device space. There should be incentives for start- up similar projects elsewhere in the country.
ups and industry to go for embedded technologies that are Several medical and equipment companies from coun-
disruptive and relevant to the Indian conditions. tries like Japan and China have already started choosing
“We have to create an ecosystem that promotes smart Indian medical equipment clusters like Andhra Pradesh
incremental innovation and spur more startups and incu- Medtech Zone (AMTZ) as their base of manufacturing.
bators,” says Dr Girish Sahini, Director General, Council Till now, due to a number of ecosystem constrains med-
of Indian Scientific and Industrial Research (CSIR). ical devices and equipment industry has not been able to
achieve its full potential
and has led to a high de-
pendence on imports to
meet the domestic demand.
The recent policy changes
leading to creation of a pre-
dictable, enabling ecosys-
tem is expected to promote
entrepreneurship, market
penetration and provide
competitive advantage to
the industry. The enabling
initiatives taken-up in this
sector by the government is
expected to set the ball roll-
ing to make India a power-
house in manufacturing of
medical devices, making
it realise its full potential
of becoming a multi-billion
industry in few years from
now.
MARCH / 2017
ehealth.eletsonline.com 13
Special Story
Karnataka
Hails CSR in
Healthcare
With the motto of “Health for All and Health Everywhere”, the
Government of Karnataka is ensuring quality healthcare services
to the people under Corporate Social Responsibility (CSR) initiative,
writes T Radhakrishna of Elets News Network (ENN).
K
arnataka is going the CSR way to improve health in- ple, two-thirds of which live in the countryside, where the
dicators and healthcare infrastructure in the state. supply of medical care and the ability to pay for services
India carries 20 per cent of the world’s disease is limited.
burden and also records the highest number of ma- Dr Shalini Rajneesh, Principal Secretary, Department
ternal deaths in the world, according to available reports. of Health and Family Welfare, Government of Karnataka,
Though India is the third largest manufacturer of pharma- says the main objective of Health and Family Welfare De-
ceuticals and has the largest number of medical schools partment, Government of Karnataka, is to provide quality
globally (381) and produces the most medical graduates healthcare services to the people. “Health for All, Health
each year (50,000). Everywhere is the motto of Government of Karnataka,”
The reason for the dichotomy is: India lacks the finan- she says.
cial resources required to reinforce its deficient health- “Our vision is to ensure access and availability of quali-
care infrastructure and improve its health indicators. ty health care for all. Our mission is to provide comprehen-
Healthcare programmes are funded by government budg- sive and quality health care services to ensure equitable
ets, international aid and charitable organisations, but the access, redress regional imbalances. Stabilise population
money isn’t quite enough for a country of 1.25 billion peo- and make AYUSH systems integral part of health care. In-
14 MARCH / 2017
ehealth.eletsonline.com
Special Story
volve community participation in all the activities for bet- The Government of Karnataka has
ter acceptance,” she further states. implemented several new programmes
Corporate Social Responsibility and strengthened the existing ongoing
There is a need for improving health indicators and also programmes in order to improve the
health infrastructure. Governments as well as regulators
have responded to this unrest and the National Voluntary health care of the community.
Guidelines for Social, Environmental and Economic Re-
sponsibilities of Business and the Corporate Social Re-
sponsibility (CSR) clause within the Companies Act, 2013 Dialysis Units
are two such instances of the steps taken. CSR can be de- It is planned to strengthen the existing units by identify-
fined as “the responsibility of enterprises for their impacts ing the gaps for the non-functioning of the units and to fill
on society”. To completely meet their social responsibility, the gaps to make the units functional by inviting PPP part-
enterprises “should have in place a process to integrate ners (human resource support viz. specialists and techni-
social, environmental, ethical human rights and consumer cians). Further, 100 taluks hospitals are to have dialysis
concerns into their business operations and core strategy units. It is proposed to have at least two machines in each
in close collaboration with their stakeholders.” taluk hospital.
Since Corporate Social Responsibility and sustainabili-
ty are so closely entwined, it can be said. It is a company’s
commitment to its stakeholders to conduct business in an
Mobile Health Clinic (MHC)
Aims to take quality healthcare delivery to the door steps
economically, socially and environmentally sustainable
of the vulnerable sections of the population in remote, un-
manner that is transparent and ethical.
reached and poorly accessible under-served areas of Kar-
nataka (rural, hilly, tribal and forest with poor communi-
New Programmes in Karnataka cation facilities). The government is proposing to deploy
The Government of Karna-
taka has implemented sev-
eral new programmes and
strengthened the existing on-
going programmes in order
to improve the health care of
the community. Various bene-
ficiary oriented schemes are
implemented by the Govern-
ment of Karnataka in addi-
tion to the existing schemes.
Though the public health
programmes are implement-
ed by the government, the
success of the programmes
is largely dependent on the
participation of the commu-
nity, along with the involve-
ment of the philanthropists,
corporates, non-government
organisations, charitable in-
stitutions, etc. The Government of Karnataka is open for 1,000 Ambulance for this purpose.
the Corporate Social Responsibility support for effective
implementation of the health schemes, say officers work- Citizen Help Desk
ing on the new programmes. In the first stage, the follow- Despite of good infrastructure, public health facilities in
ing programmes are identified for CSR support: urban and semi-urban areas lack quality and reliability.
The main reasons are urban poor lack awareness on avail-
Araike Yojane able services, poor grievance redressal system and lack
Under this scheme, provision will be made to provide pure of information on patient rights, privileges and responsi-
drinking water, toilet, bathroom facility and rooms to stay bilities. Hence, Citizen Help Desk (CHD) are required to
for the patient’s attendants. It is proposed to implement improve utilisation of available hospital services. It is pro-
this scheme in all the 21 district hospitals and 146 taluka posed to start CHD in 146 taluk level hospitals of the state
hospitals of the state. through CSR mode.
MARCH / 2017
ehealth.eletsonline.com 15
Special Story
16 MARCH / 2017
ehealth.eletsonline.com
Special Story
MARCH / 2017
ehealth.eletsonline.com 17
Special Story
18 MARCH / 2017
ehealth.eletsonline.com
Special Story
MARCH / 2017
ehealth.eletsonline.com 19
Company at a Glance
Anand Medicaids:
A Legacy of Quality,
Innovation
Anand Medicaids, a leading Indian manufacturer and exporter of
suction equipment and accessories, is taking forward its 40 years old
legacy of quality products, innovation and good customer service.
Continual innovation and high standards of quality have been the
driving factors behind the company’s phenomenal growth and
success.
I
t takes an intense commitment over 1,100 sq. meters, the facility a period of up to 10 years after sale.
and concentrated effort to sepa- is equipped with the latest machin- Continual innovation and high
rate a specialist from a practition- ery for online assembling of suction standards of quality have been the
er. Anand Medicaids Private Lim- equipment in dust free environment. driving factors behind the company’s
ited, an institution built four decades The factory organisation includes phenomenal growth and success. The
ago, truly understands this principle different divisions, such as produc- company’s production and quality
and displays it in every initiative. And tion, assembly, testing, clean room standards are supported by certifi-
this understanding has made Anand and R&D. It also provides in-house cations from the leading evaluation
Medicaids the specialists in providing facilities for development of dies and agencies. Anand suction equipment
high quality suction units - cost effec- molds. was the first company to be awarded
tively. Customer service is another main the ISI Mark in 1985. The company
Today, Anand Medicaids is the focus area of the company. The com- was the first company in India to be
leading company from India engaged pany has excellent reach through awarded the CE & ISO 9001:2008 and
in manufacture and export of suction a sales network comprising deal- ISO 13485:2003 certifications for suc-
equipment and accessories. ers and retailers, spread across the tion units.
Quality is the company’s legacy, globe. The company also provides af-
which is reflected by the state-of- ter-sales service of all its products by For details, please visit www.
the-art manufacturing facility. Built providing all the tools and spares for anandind.com.
20 MARCH / 2017
ehealth.eletsonline.com
Industry Perspective
MARCH / 2017
ehealth.eletsonline.com 21
Industry Speaks
The Architecture of
Healing RSMS is a leading healthcare design firm that has been
working closely with healthcare providers for over a
decade, building strong ties with clients and continuously
adopting to the latest best practices in healthcare, says
Manu Malhotra, Founder Partner at RSMS Architects, in an interview
with Elets News Network (ENN) while sharing an insights into hospital
design process and key differentiators that guide methodology
and process at RSMS.
What are the focus areas for malcy of the world outside the facility.
RSMS in the healthcare sector? Family spaces form important areas
RSMS Architects focuses on con- of our hospital designs as does the
stantly updating, innovating and im- material palette, which reflects visual
proving past projects and past expe- as well as haptic warmth and comfort
riences. We approach every project to offset the mechanical and often
with a fresh mind, seeking to find out intimidating features of diagnos-
better practices adopted across the tic-treatment areas. Colour, as much
fields of healthcare and construction as material, is important in this as-
and integrating the same into the ex- pect and the palette of architectural
isting template of our experience. We finishes in a hospital should include
have tried to achieve this by constant- warm and vibrant colours in patient
ly interacting with healthcare profes- zones and visitor zones.
sionals across diverse specialities Another feeling that often over-
and services to understand various whelms the patient is one of isola-
points of concern that they face. tion, which can lead to depression.
Another focus area of ours is to un- One way to avoid this is to have a
derstand the different challenges of sensory connection between the in-
working in new environments. Tak- terior and exterior. While optimising
ing advantage of working in a diverse the space to provide the best ergo-
country such as ours, we have honed nomic comfort, we introduce healing
our skills to understand different courtyards, terrace gardens, playing
mindsets, construction technologies, areas for children and so on. These
design sensibilities and economic form vitally important buffer spaces
models. Included to this information in the facility while providing much
bank are the relevant local bye-laws, required soothing respite.
geographic and climatic data. This Architectural fenestration is a
helps us to quickly derive ideas and very important part of hospital design
working solutions custom designed as well. Studies have shown the pres-
for each project. ence of natural daylight in patient ar-
eas leading to a reduction in patient
What role do architectural stay duration by as much as 25 per
structures play in ensuring the cent. Staff productivity has also been
well being of a patient? known to increase by 8 percent. The
Spatial design has the ability to alter increased productivity leads to better
the users’ state of mind. Patients en- patient care and boosts staff morale.
tering healthcare facilities are usual- To derive the best curative benefits of
ly under mental and physical stress. sunlight, we carefully select the glass
In order to create a recuperative at- that we use based on building ori-
mosphere, we try to create an envi- entation, aesthetic appeal, size and
ronment which best mirrors the nor- function of the fenestration in order
22 MARCH / 2017
ehealth.eletsonline.com
Industry Speaks
MARCH / 2017
ehealth.eletsonline.com 23
Industry Perspective
Fostering Medtech
Innovations in India
Having evolved significantly in the last decade, the Indian medtech industry
is witnessing a high growth trajectory. But due to a number of ecosystem
constraints, this industry sector has not been able to achieve its full potential.
The recent policy changes initiated by the government to create a predictable
and enabling ecosystem are expected to set the ball rolling to make India a
powerhouse in manufacturing of medical devices, writes Dr Suchita Markan,
Assistant General Manager in Biotech Consortium India Limited (BCIL) for Elets
News Network (ENN).
T
o foster any medical device innovation, we need mar- reality. Recognising the immense growth potential of med-
ket push and technology generators such as trained ical device sector, the Government of India has identified
manpower to generate ideas; funding opportunities the medical devices industry as a sunshine sector for the
for nurturing the idea; intellectual property (IP) ‘Make in India’ initiative. Since 2014, India has witnessed
protection to protect intellectual assets; infrastructure to numerous fiscal initiatives and policy changes which led
seed the IP or technology into a company set-up; and tax to the development of a robust and enabling ecosystem for
incentives or policies for ease of doing business. this sector.
Besides these, well-oriented regulatory policies are re- To realise the full potential of Medtech sector, the gov-
quired for developing and scaling-up regulatory compliant ernment has taken several steps and policy initiatives in-
technologies and mechanisms for supporting technology cluding initiatives to facilitate ease of doing business, tax
absorption and market access for the benefit of the nation incentives to boost domestic manufacturing, 100 per cent
and the economy at large. FDI to attract foreign investments, predictable regulatory
regime to boost con- fidence of investors to develop quali-
Environment is Conducive for Innovation ty medical devices and setting-up exclusive infrastructure
Today, India offers a unique and dynamic platform for nur- facilities, etc
turing medical device innovations to transform ideas into Although these policy initiatives were taken-up over a
24 MARCH / 2017
ehealth.eletsonline.com
Industry Perspective
period and were functioning in silos, but as a whole, these versities of Australia, Japan etc. with BCIL as techno-legal
led to creation of an incredible enabling ecosystem to management partner.
boost medical technology innovation and manufacturing These programs are creating medical technology in-
in the country. novators, multiple innovative medical device technolo-
The medical device industry in India is a multi-prod- gies and start-ups which are making a huge impact. Pro-
uct industry offering plethora of diverse products ranging grammes like SIB are promoting startup entrepreneurship
from low technology medical disposables, technology driv- which is crucial for developing innovations, creating new
en ophthalmic products, imaging, medical equipments, di- jobs and introducing competitive dynamics into the busi-
agnostics, dental equipment to high-end innovative class ness envi- ronment.
III devices such as drug eluting stents, emergency health-
care devices, robotics etc. Funding Support
At present, the Indian medical devices industry is frag- Funding is an essential ingredient for technology develop-
mented into small and medium enterprise category and ment. Today, India offers plethora of funding opportunities
is primarily manufacturing products such as disposables from government and private players for all the stages of
or medical supplies. Requirement for high-end medical technology development and commercialisation including
equipments are met by multinational companies. It is esti- ideation stage, proof-of-concept, technology validation,
mated that there are about 800 indigenous manufacturers scale-up and commercialisation.
in the country, primarily in the low-tech domain. Domestic Adequate funding opportunities are available in India
firms generally participate in the low priced, high volume for supporting scientific, technical, intellectual property,
market segment wherein competition is intense. MNCs are business, marketing and distribution dimensions of a suc-
generally not much engaged in manufacturing and R&D cessful medical device venture. SBIRI, BIG, BIPP, SPARSH,
but primarily in marketing value added, imported tech- Grand Challenge India, CRS, TDB, etc., are the funding
nology driven products in India. However, after the recent schemes which can be availed by medtech enterprises and
spur of ‘Make in India’ campaign, some manufacturing entrepreneurs. Apart from government funding sources,
companies are now shifting their focus from capturing the international funders, VCs and angel investors also pro-
market share to market creation. They are discovering in- vide funding support to path breaking, innovative technol-
novative products for market niches. ogy solutions. The funding that can be availed ranges from
MARCH / 2017
ehealth.eletsonline.com 25
Industry Perspective
26 MARCH / 2017
ehealth.eletsonline.com
Industry Perspective
@ehealthmagazine @ehealthonline ehealthmagazine
Events
Calendar
ehealth.eletsonline.com
Pharma 7th
Healthcare
CIO Healthcare
Summit
Symposium Leaders
11th APRIL Forum
21st APRIL
JUNE
BENGALURU
MUMBAI NEW DELHI
3rd
Healthcare
Healthcare
Summit
Summit,
JULY Rajasthan
SEPTEMBER
HYDERABAD
JAIPUR
MARCH / 2017
ehealth.eletsonline.com 27
Industry Perspective
cal devices for patients. This medical device park with The new Rules have been framed
three main USPs – scientific facilities, affordable space
and plug-and-play ecosystem is going to provide a major in conformity with Global
thrust to the indigenous manufacturing of cost-effective
and quality medical devices for India and global markets.
Harmonisation Task Force (GHTF)
framework and conform to best
Other Major Steps international practices.
To further create an enabling environment, various other
fiscal initiatives have been taken-up by the government in South Korea. However, the per capita spend on medical
the past couple of years including introduction of 100 per devices in India is the lowest among the BRIC countries
cent FDI policy to attract foreign investments in 2015; cor- at $3 ($7 in China, $21 in Brazil and $42 in Russia). It
rection of inverted duty structure on import of raw materi- is significantly behind developed economies like the US
als for medical device manufacturing in January 2016; and ($340). This current under–penetration of medical de-
notification of Medical device rules recently in February vices in India represents a sizeable growth opportunity.
2017. The inflow of foreign direct investment (FDI) in medical
The new rules have been framed in conformity with devices was $90 million between December 2014 and Au-
Global Harmonisation Task Force (GHTF) framework and gust 2015, post the government permitting 100 per cent
conform to best international practices. Only 15 catego- FDI under the automatic route. Several MNCs have been
ries of medical devices are at present regulated as drugs increasing their manufacturing footprint and locating re-
and, to that extent, the current regulatory practices in In- search centres in India to serve both the Indian and global
dia were not fully geared to meet the requirements of med- markets.
ical devices sector in the country. The new Rules seek to From the consumers’ perspective, it is imperative that
remove regulatory bottlenecks to Make in India, facilitate apart from creating a favourable policy framework and
ease of doing business while ensuring availability of better support structure fostering medtech innovations in India,
medical devices for patient care and safety. These rules suitable steps also need to be taken in order to bring about
envisage creation of a robust ecosystem for all stake-hold- a change in the mindset of all the stakeholders more par-
ers including innovators, manufacturers, suppliers, con- ticularly, the intended users, so that the “Made in India”
sumers, buyers and regulators. devices become more acceptable for adoption and use in
Indian medical device industry is worth over `60,000 India.
crore and country’s humungous import bill for this seg-
ment amounts to over `23,000 crore (approximately $4 bil-
lion) while exports amount to only over `7,000 crore ($1.1 About the Author
billion). India’s import dependency on high-end medical
devices is over 80 per cent. The global medical devices and
technology market is expected to grow to $520 billion by
2020. The Indian market is among the top 20 in the world
by market size, and fourth in Asia after Japan, China and
HR/Manpower Funding
28 MARCH / 2017
ehealth.eletsonline.com
Industry Perspective
4 POWER
PACKED
MAGAZINES
A QUALITY MAGAZINE
ON BANKING AND FINANCE
ASIA’S FIRST
MONTHLY
MAGAZINE
ON ICT IN
ASIA’S FIRST MONTHLY
EDUCATION
MAGAZINE ON e-GOVERNANCE
SUBSCRIBE TO
SUBSCRIPTION ORDER CARD eHealth NOW
Duration Issues Subscription Newsstand Subscription Savings
(Year) USD Price INR Price INR
1 12 300 900 900 --
2 24 500 1800 1500 `300
3 36 750 2700 2000 `700
*Please make cheque/dd in favour of Elets Technomedia Pvt. Ltd., payable at New Delhi
I would like to subscribe: egov digitalLEARNING eHEALTH The Banking & Finance Post
Contact: Elets Technomedia Pvt Ltd — Stellar IT Park, Office No: 7A/7B, 5th Floor, Annexe Building, C-25, Sector 62, Noida, Uttar Pradesh 201301,
Phone: +91-120-4812600 Fax: +91-120-4812660, Email: subscription@elets.in
Subscription Terms & Conditions: Payments for mailed subscriptions are only accepted via cheque or demand draft • Cash payments may be made in person
• Please add `50 for outstation cheque • Allow four weeks for processing of your subscription • International subscription is inclusive of postal charges.
R
esearch laboratories at Sami-Sabinsa Group en- brand finds a place in many of the Sami Direct products
deavour to bring out products with the goal of “De- today,” explains Shaheen Majeed, Director, Sami-Sabinsa
sign to Delivery”. To achieve this goal, several inde- Group. To facilitate the increased demand for innovative
pendent divisions work in synergy to make products application-based products, Sami Labs Limited (formerly
that meet international standards. Sami Chemicals & Extracts Ltd) was set up in 1991 in Ben-
For the past seven years, Sami Direct, a subsidiary of galuru as a R&D facility. Today, the main ocus of Sami is on
Sami Labs, has been marketing across India a range of nu- new product development and market oriented research.
traceutical and cosmeceutical products, covering weight
management, bone strength, liver strength, detox supple-
ments, skin and beauty care etc. R&D Division Providing a Solid Foundation
The company’s nutraceutical product range includes for Business Development
Bioprotectant, Calci D Max and Cran DM Plus, to name a Research is a broad term that includes basic research and
few. Johara cosmeceuticals, the beauty brand of Sami Di- applied research. Many companies, especially in India,
rect, uses hand-picked time-tested botanical ingredients focus on applied research which is the practical applica-
that have evolved from pure science and scripted in many tion of research. However, the need of the hour is basic re-
ancient texts across the world. search which the world over has gained more importance,
“Our skin care formulae will always be free of parabens, says Majeed.
sulfate, synthetic dye or formaldehyde and will always R&D has been pushing breakthrough innovations and
have standardised botanical extracts and be clinically acting as a catalyst for speeding up the pace of growth of
relevant. From the cultivation to the standardisation, our the company through large scale production. Sami Labs
group holds several international patents and accolades invests 6-7 per cent of its annual turnover in R&D alone,
on this ingredient, branded as Curcumin C3 Complex. This he adds.
30 MARCH / 2017
ehealth.eletsonline.com
Industry Perspective
While other companies allocate less than 10 per cent facilities, one located in Hyderabad and the rest near Ben-
of space for research, Sami Labs has dedicated almost an galuru.
entire facility to research. “The number of patented prod- While several of these facilities are suited for herbal
ucts of Sami Labs/Sabinsa Group is the proof that the re- extraction, one facility is only dedicated to probiotic pro-
search here is result-oriented. At present, we have over duction through fermentation technology.
130 International patents to our credit,” says Majeed. “The probiotic we produce requires no refrigeration
Unlike other organisations in the space, Sami Labs and, therefore, can be used in several delivery formats,
houses a research facility with over 120 scientists involved it’s a great seller world-wide,” he says.
in specialised work in areas of phytochemistry, organic “One of our units is the first in Asia using indigenous
chemistry, tissue culture, plant biotechnology, biochemical super critical fluid extract technology. This is an alcohol
pharmacology and clinical research. free set-up for extracting natural extracts. In terms of
The recent patents are comprised of ingredients such meeting world demand for ingredients such as Curcum-
as stilbenoids, peptides, 3-hydroxypterostilbene and in and coleus forskolhii, we have a continuous extrac-
boswellic acids in countries like China, New Zealand, the tion plant in place, and a second one is being built as we
US, Canada and Mexico. speak,” Majeed says.
The products help in hypercholesterolemia, weight “Continuous extraction technology helps to scale up
management, skin aging treatments, inhibiting and pre- from vessel based input of about 1 or 2 tonnes to nearly
venting adipogenesis, protecting articular cartilage and 20-25 tonnes of material, thereby increasing our output to
even a hepatoprotectant molecule. meet and exceed world demand,” he adds.
The current R&D impetus of the Sami-Sabinsa Group
focuses strongly on immunological basis of disease man- Growth of IT in Pharmaceutical Industry
agement based on natural principles. With precise sci- Digital marketing has considerably impacted the growth
entific evidence generation at the basic, pre-clinical, and of pharma industry in a good way. The commercial promo-
clinical research stages, the group believes in creating tion of strategies for public health can be done effectively
reliable and responsible science. This objective has been by digital marketing.
recognised by the intellectual property systems across the “At present, most digital marketing efforts focus on
globe, according to Majeed. specialists and patients, and not on general practitioners.
Mobile networking is still in its infancy but mobile phone
Manufacturing Facilities is the most engaging personal screen for any physician.
On the manufacturing front, Sami Labs has a contract Hence, efforts in this area could prove worthwhile for
manufacturing unit located at Payson city in Utah County brands looking to connect,” says Majeed.
of the US. This facility is a state-of-the-art finished goods
manufacturing centre, producing capsules, tablets and Role of Technology and Data in Shaping
bi-layer tablets with ingredients from Sabinsa and others
Digital Marketing in Healthcare
for its customers worldwide.
The main goal of technology and digital marketing in
In India, Sami Labs have six ingredient manufacturing
healthcare is to provide information at any time, in any
place. The continuously rising cost of healthcare servic-
es is a problem and burdens the whole economy. Digital
ICT ENHANCING OFFERINGS health technologies can reduce the price by centralising
the care, according to the Director of Sami-Sabinsa Group.
• ICT, better known as Information
For example, ECG data can be fed in the system/mobile
Communications Technology, concerns itself with
phone of the medical centre and a physician can access
storage, retrieval, manipulation, transmission and
within a short period of time and provide the treatment
receipt of digital data.
without any delay to the patient.
• This data is communicated electronically to the
“Most people actively check online for healthcare
people by different means such as emails, social
solutions. Digital marketing includes mobile marketing,
media sites like Facebook, Twitter, etc. Integration
search engine marketing, social media marketing, etc.
and execution of ICT has reinforced and enhanced
These techniques are inexpensive and more powerful than
our skills which has developed our researches,
the traditional marketing. This kind of information, which
promotions, offerings, etc.
is considered dynamic and not static, will reach consum-
• All the research, new promotions, latest news are
ers in a short period of time and can be updated more fre-
circulated through social media outlets like Face-
quently than traditional methods. This can increase the
book, Research Gate, Twitter, and LinkedIn accounts.
patient’s satisfaction, improve care and lower costs,” he
Hence, the latest offerings and research we have
opines.
on our products reach the intended audience group
Also, social media has gained prominence among pro-
much faster -- bringing to them solutions they can
fessionals from different industry verticals for networking
use right away to affect their lives.
and is serving the customers with customised solutions.
MARCH / 2017
ehealth.eletsonline.com 31
Industry Perspective
Pharma
Undergoing
Paradigm
Shift
There has been a paradigm shift
in the way the government is now
interacting with the pharma industry
– from one of assertiveness and
insistence; it has now become one of
collaboration and assistance, says Vishal
Rajgarhia, Director & CEO, Finecure
Pharmaceuticals Ltd, in conversation
with Elets News Network (ENN).
How is ‘Make in India’ helping a web portal and easing of statutory lenge and make us less complacent
Finecure Pharmaceuticals boost and regulatory procedures means and motivate us to higher standards
its manufacturing capabilities? that the pharma companies will at of customer satisfaction and product
‘Make in India’ is one of the major last be able to work to their full po- innovation.
reforms that our Prime Minister tential. There has been a paradigm
(Narendra Modi) has taken and it is shift in the way the governent is now What implications do you see
certainly going to boost the pharma interacting with the pharma indus- for the pharma sector once it
industry, given that the pharmaceuti- try – from one of assertiveness and is delinked from the medical
cal industry is one of the 25 key sec- insistence; it has now become one of devices industry?
tors that the government has identi- collaboration and assistance. There To be honest and fair to the govern-
fied as a potential sector for foreign will be new infrastructure and a ment, over the last many years, many
companies to invest in. Furthermore, new mindset where we will be com- attempts had been made to enact a
a dedicated team to respond imme- peting with the best. Furthermore, law regulating medical devices but
diately to business entities through increased competition will fuel chal- somehow it could never be done. It
32 MARCH / 2017
ehealth.eletsonline.com
Industry Perspective
is also true that nowhere else in the The arrival of Internet of Things it to develop new products and ser-
world are the pharma and medical (IoT), big data analytics and artifi- vices that drive growth and progress.
device sectors governed by the same cial intelligence has woken up the The government should do more to
set of regulations. So, the delinking pharma industry and made it aware increase this awareness and also in-
was inevitable, something that was of its immense potential and its abil- itiate incentives and programs that
waiting to happen. I personally feel ity to bring the Indian pharma indus- will motivate the industry to channel
that it is a step in the right direction. try on par with the best in the world. their resources towards research
It is a policy decision and the inten- IoT, big data analytics and artificial and development. Without doubt the
tion of the government should be intelligence are the future of the landscape of partnership between
respected and appreciated. My only pharma industry in India. The ability academia and industry has to be
concern is that since the medical to convert massive amounts of data expanded and become a prominent
devices industry is in an embryonic into key performance indicators, the feature in the industry. It does seem
stage and was so heavily dependent ability to check their plants from counter-productive to share data
on the pharmaceuticals industry for anywhere in the world over their and give away information that can
its nourishment, there could be prob- smart phones, identifying potential negatively impact business but the
lems that we cannot foresee for the problems and implement corrective benefits of collaboration are huge. It
moment. There certainly was scope action, it has offered a new pathway will provide access to new talent and
for a gradual phasing and delinking to pharma companies to develop ac- modernisation and enlarged convic-
of the two industries. But it has made tionable insights, organize their fu- tion and clearness with customers
price control for medical devices a re- ture vision, boost up the outcomes and other stakeholders. These ad-
ality and thumbs up to that. and reduce time to value regarding vantages will happen not only for the
The lack of a regulatory frame- their management, planning and the pharma companies but also for the
work along international lines, the measurements. Logistical planning academia. it’s a win-win situation for
industry body felt, has been a major becomes that much easier and pro- all concerned.
factor as investors were discouraged duction costs will become lower and
by the initial move of 22 medical de- increase productivity and efficiency.
vices being regulated as drugs by It is a blessing and boon to the indus- What key challenges do you
CDSCO and state drug controllers. try and will change the face of how see impeding the growth of the
The government has taken the first we work. Indian pharma sector?
step in the appropriate direction. There are many factors that hinder
But there needs to be a separate law Promoting R&D, innovation and us from realizing our full potential
book, separate rule book and sepa- discoveries in technologies and but instead of looking at them as im-
pediments I look upon them as chal-
rate regulatory authority. molecules in Indian context is
lenges that need to be overcome so
the need of the hour. How is
The government has taken India placed with regard to the
that the Indian pharmaceuticals in-
the first step in the appropriate dustry can achieve its potential and
industry-academia partnership convert these challenges into success
direction. But there needs to be for promoting innovations in the
a separate law book, separate stories. However, for this to happen it
pharma sector? needs the support of the policymak-
rule book and separate regHow We must confess and agree that most ers, academia and financial inves-
do you see IoT, big data ana- pharma companies are under invest- tors and all other stakeholders. How-
lytics, and artificial intelligence ing in research and development ever, since a question has been posed
impacting the pharma sector? (R&D). Offhand I cannot name even a I would say that the three biggest im-
What role these latest technol- single company that has tie-ups with pediments are an unsatisfactory en-
ogies are to play in improving the research academia. R&D is the ergy infrastructure and poor trans-
inefficiencies across the sector? backbone of any company and helps port infrastructure. India needs to
focus on API to remove dependency
on imports of bulk drugs for making
drugs. The industry needs to focus
on innovative drugs and value addi-
tion instead of just making generic
drugs. The GMP issuance should be
for a longer period and GMP should
be recognized in other countries so
that they do not need to re-inspect
facility having Indian GMP which will
give Indian Products a better brand
value and revenue.
MARCH / 2017
ehealth.eletsonline.com 33
Leaders’ Perspective
New Era
of Medical
Device
Industry on
the Anvil
India is growing as a key market for medical devices. The tremendous growth of the
medical devices industry over the last decade and the current development trends
are indicative of the industry’s great potential. Probir Das, Managing Director,
Terumo and Chairman-Medical Devices Forum, FICCI, in conversation with Rajbala
of Elets News Network (ENN), highlights future prospects of the industry in the light of
fresh reforms introduced to push growth.
Please share your views on the Medical device will soon be What are the key opportunities
future of medical device indus- delinked from the pharma sec- for Indian medical devices and
try in India. tor and form a separate minis- equipment industry?
The medical device industry in India try. How is it going to boost the As a country, we have huge need
has a huge potential. As per reports, medical devices sector? and, therefore, a big opportunity.
the industry is projected to grow from The potential formation of a sepa- However, whether that big opportu-
its current $7-8 billion size to about rate ministry for the medical devices nity translates into demand and that
$20 billion through an organic growth industry will shape the industry in a demand translates into market size
model, and to reach $50 billion more structured manner. It will facil- are dependent on several things like
through an inorganic growth model. itate new rules and policies for this improvement in healthcare penetra-
This growth will come on the back industry. It will also help to develop tion. Medical devices is an ancillary
of new policies, regulations, infra- end-to-end support system on regula- industry and adoption of technology in
structure, technology collaborations tory as well as policy front, provide a India, as the current adoption level of
and strategic alliances with interna- boost to the R&D infrastructure, pro- medical devices at $3 per capita is one
tional players to focus on relevant mote investment, offer a platform for of the lowest in the world.
markets globally. improving the start-up ecosystem; fa- In the growing medical technolo-
Increase in number of hospitals, cilitate development of a focused ap- gy market, it is important for enter-
healthcare service delivery and, proach to foster innovation, promote prises and the government to build
consequently, a greater need for ac- education and skill development for global competitiveness and adopt
cessible as well as quality medical the medical devices industry, create a risk-based approach to develop a
devices,is also expected to drive the deep understanding of the industry, sound and comprehensive global sup-
growth of medical devices and equip- and help develop a distinct identity of ply chain management system that
ment industry. the industry. ensures the product quality, integ-
34 FEBRUARY / 2017
ehealth.eletsonline.com
Leaders’ Perspective
rity and identity which is preserved ♦ Boost government’s ‘Make in In- rum brought together the highest
throughout the supply chain. dia’ campaign by providing an en- decision makers from the industry,
The important fact is that global vironment conducive to domestic government, policy makers, interna-
supply chain will determine our com- manufacturers that could lead to tional regulators, etc to discuss on
petitiveness. greater long-term investments. overall growth of the industry and
The new rules will be effective from encourage ‘Make in India’ for manu-
Please tell us about the impli- January 2018. In this transition peri- facturing of medical technology.
cations of new rules and regu- od necessary changes or distinct in- The outcomes of the forum meet
lations for the Medical Devices terventions can be made such as: were:
notified recently. How will the ♦ Expiry of medical devices ♦ Realisation to craft a medical tech-
new rules remove regulatory ♦ Classification of devices on cate- nology 2020 vision.
gories ♦ Appropriate debate on whether to
bottlenecks?
♦ Formulation of totally separate act support protectionism or drive com-
The medical devices industry was
for medical devices from Drugs petitiveness of domestic manufac-
regulated under the Drugs and Cos-
and Cosmetics Act. turing.
metics Act for several years. But af-
ter years of dialogue, the government ♦ Debate on whether to only focus
has finally notified a draft of new on Make in India or also ‘Develop
FICCI and the Central govern- in India’.
rules and regulations for medical de-
ment hosted ‘India Medical ♦ Introduction of Health Technology
vices industry by separating it from
Device 2017’ in Bengaluru Assessment.
the pharmaceutical industry.
recently to increase overall
♦ New rules will be able to ease
norms for obtaining license and growth of domestic production Medical device sector is to
conducting clinical trials. and growth in the sector. What be included as one of the 25
♦ Will reduce manufacturer-regula- were the key takeaways from flagship industries of the Indian
tor interface by promoting digital this international event? economy. What does it mean
platform. The ‘India Medical Device 2017’ fo- for the industry?
The medical devices industry has
gained its rightful place in the list of
MEDICAL DEVICES CONSUMPTION IN US DOLLARS 25 flagship industries of the Indian
economy. This will cause a shift in
India is compared on healthcare delivery parameters with the industry’s structure, conduct and
countries like China, Brazil, Russia, etc. Seeing the medical devices con- performance. Medical device indus-
sumption across the world, there is a pressing need to improve per capita try is comparatively very young and
medical device consumption in India. complex. Being a part of the ‘Make in
India’ initiative will be valuable for its
Medical devices consumption per capita in terms of US dollar: growth. The government’s task force
will address the pressing issues and
make recommendations to assist the
industry.
CHINA - $178
INDIA - $3
MARCH / 2017
ehealth.eletsonline.com 35
Industry Perspective
Netmeds.com: Building
Trust, Ensuring The Indian retail pharma
36 MARCH / 2017
ehealth.eletsonline.com
Industry Perspective
Could you please apprise us as a one-stop, easy accessible shop superior online shopping experience,
about the marketing initiatives for patients seeking medicines and which includes ease of navigation
being taken by Netmeds for health and wellness needs to be a and absolute transactional security.
brand promotion? provider of reliable, authentic and
Every day should be marketing ini- approved medication; and doorstep How Netmeds or other e-phar-
tiative for any successful brand who delivery of medicines in tier two and macies are penetrating and
serves the customers. In this space, tier 3three cities. capturing the market in Tier
we have to understand that we are two and Tier three cities? Can
not building a brand but we are build- How safe is to procure medi- you tell us about the expansion
ing a category. cines online? plans of Netmeds?
The important fact is that along It’s perfectly safe if the patient or Netmeds continues to deliver its ser-
with the promotion of the brand, Net- customer has a valid prescription vices to every state in India and have
meds also designs and broadcasts written by a doctor. The medicines delivered in more than 800 cities. The
messages to create accessibility must be dispensed only by pharma- company has planned to keep improv-
for medicines digitally. It’s been ex- cist once the prescription is reviewed. ing its service, coverage and continue
tremely satisfying to see how well the Netmeds operates as all online phar- to learn from customers.
concept has been accepted and has macies should operate. Company will soon be launching a
created desirable disruption of pre- A qualified team of certified phar- social networking challenge to deliv-
viously accepted paradigms in India. macists approves and digitises every er its services in remote areas of the
The whole idea of e-pharmacy transcription. We are committed to country.
was conceptualised to offer medi- provide safe, reliable and affordable Currently, Netmeds has over a mil-
cines and generics for the conven- medicines as well as a customer ser- lion registered users and the number
ience of the customers keeping in vice philosophy that is worthy of our is growing at the rate of around 10
mind the affordability element to act valued customers’ loyalty. We offer a per cent month on month basis. Hav-
ing the ability to deliver our services
in 800 cities, we hope to continue to
BENEFITS OF ORDERING MEDICINES ONLINE expand the scope of our services in
every state of the country. Our en-
• Affordable lower prices and no expired drugs on sale deavour is to continue deepen our
• Privacy/Anonymity — You may feel more comfortable purchasing your penetration in every state, especially
medication online, or simply want to speak to someone about prescrip- the remote areas.
tions and your health online or over the phone rather than in person.
What according to you is the
However, to prevent the use of your personal information for unau-
thorised purposes, make sure the pharmacy has an appropriate privacy USP of the company?
policy. This is one of the things that PharmacyChecker.com checks for Netmeds is the only fully licensed on-
you. line pharmacy to serve all of India.
• Convenience — If one finds it physically difficult to make it to the It has delivered in nearly 800 cities
pharmacy, living in a remote rural area mail-order pharmacies enable across every state in the country.
consumer to buy medicine sitting at corner. It will also remind you when The company employs more than 400
you can order a refill to help you maintain your regimen. staff including pharmacists, pharma-
• Medical information — Some online pharmacies provide useful informa- cy technicians, customer service spe-
tion about medications and diseases as well as links to medical resourc- cialists, logistics and warehouse ex-
es such as universities, government agencies, and health associations. perts, digital payments professionals
and programmers.
MARCH / 2017
ehealth.eletsonline.com 37
Industry Perspective
Care24: Ensuring
Healthcare at
Doorsteps Care24 is a first-of-its-kind home healthcare
service provider in Mumbai that offers
personal and affordable healthcare
assistance within the comforts of one’s
home, Vipin Pathak, Co-founder and
CEO, Care24, in an interview with Elets
News Network (ENN) talks about how
his company aims to achieve 10 per
cent market share of the $3 billion home
healthcare industry.
38 MARCH / 2017
ehealth.eletsonline.com
Industry Perspective
egivers on the basis of a stringent What are the issues pertaining competitive compared to its peers in
background verification procedure, to home healthcare? Asia and Western countries. The cost
followed by on-boarding and diligent Healthcare in India is a very unor- of surgery here, for instance, is about
training. We also conduct medical ganised sector, and home healthcare one-tenth of that in the US or Western
interviews and test their capabilities is an even smaller, though growing, Europe. Also, amid the rapidly in-
through assignments and competitive segment. The biggest challenge of a creasing burden of chronic diseases,
analysis. specialised healthcare business such and the demand for quality medical
as ours remains in the areas of edu- care, especially for the elderly, the
How is it different from other cation and awareness. In a country market is now opening up for home-
existing players? like ours where many are still una- based healthcare services. According
What sets Care24 apart are its ware of home healthcare and its ben- to a research report by Cyber Me-
training programmes. In fact, we efits, educating the patients and their dia Research(CMR), the market for
only exist because of our training families has been a major focus area home healthcare in India is project-
programmes that add value to the for us. Apart from this, finding skilled ed to reach USD 6.2 Billion by 2020
unskilled workforce, helping them staff in the healthcare industry is at a Compund Annual Growth Rate
enhance the quality of their work another challenge, but one that has (CAGR) of 18 per cent.
and earn higher remuneration at the a solution, and one which Care24 is
same time. committed to solving. What is the role of technology in
There is a large pool of providers the healthcare industry?
to pick from, and we are continuous- Your current state of healthcare Rapidly transforming medical tech-
ly improving our technology to match options for the geriatric popula- nology and the availability of tech-
patients with caregivers as quickly tion in India and home health- nologically advanced diagnostic and
as possible and improve communica- care services industry per se? therapeutic equipment together with
tion. Currently, chronic care for patients changing practice pattern of doctors
who need long term care constitute has revolutionised the way health
What are your plans for the around 60% of our patient pool and care is being delivered today. Today,
year ahead? we have also forayed into cancer care, patient care experiences are top pri-
The home healthcare industry is elderly care, maternity care, and in- ority in the healthcare industry across
pegged at approximately $3 billion, fant care, besides offering expertise the globe.
and we aim to achieve 10 per cent in post surgical care and stroke reha-
market share in the long term. Also, bilitation. We have also expanded our What are your investment plans
we aim to take the patient count to portfolio to add services for diagnos- for the current year?
around 2,500 per day from the cur- tics, pharmacy delivery and medical Technology, medical expertise and
rent 900 per day, as we spread to oth- equipments procurement. The idea is expansion are our three dimensions
er metros in the country. to create a complete healthcare eco- which require investment. We would
We also plan to integrate con- system for any patient in the home continue our investment in further
nected devices, like health sensors, environment. We feel that it will make logistic automation, integrated medi-
into our platform so providers don’t the patients and their families more cal devices, remote monitoring, train-
have to make home visits to conduct in control of their well-being than ing and geographical expansion in
routine checks, like vitals and blood ever before. next six-nine months. We are serving
pressure measurements. We also nearly 900 patients in Mumbai. We
want to connect the home-bound pa- How has the overall growth want to extend the services in other
tient with his doctor and hospital in a been of healthcare industry in cities maintaining highest quality of
much more meaningful way India? service. Quality service needs an in-
Over the past decade, there have been vestment mindset to curate the right
What are your target cities? massive advancements in the health- skill set and behaviour. We have and
Our focus remains to enter a city and care industry in India, owing to well continue our different condition based
establish a strong foothold within that trained personnel, better diagnostic training like cancer care, rehab care,
city with a depth of services and net- technology and superior quality med- infant care and so on.
work as opposed to achieving scale ical equipment. The overall Indian
through a multiple city footprint. healthcare market is worth approx What is your revenue mix?
We have recently started opera- $100 billion and is expected to grow to In 2016, we raised $4 million in our
tions in Delhi-NCR and plan to follow $280 billion by 2020. This has resulted Series A round led by venture capi-
it up to at least two other cities by the in India becoming a hub for medical tal firm SAIF Partners, and $350,000
end of this year. We plan to enter the tourism, driving increase in expendi- from India Quotient that we are using
markets of Bangalore, Hyderabad, ture by public and private players. to enhance our technology and to train
Chandigarh and Ahmedabad. Moreover, India is extremely cost service providers who visit patients.
MARCH / 2017
ehealth.eletsonline.com 39
Industry Perspective
WinMagic: Securing
Data for Indian
Healthcare Industry
WinMagic helps pharmaceutical companies secure and encrypt data
at rest. Having served the healthcare industry for the past 20 years, they
bring leading industry technologies to provide unmatched security
solutions specially designed for their clients’ needs, says Rahul Kumar,
Country Manager and Director, WinMagic India, in conversation with
Rajbala of Elets News Network (ENN). Excerpts:
40 MARCH / 2017
ehealth.eletsonline.com
Industry Perspective
MARCH / 2017
ehealth.eletsonline.com 41
Leaders’ Perspective
Tell us about the Digital AIIMS care in India. It has two components – Digital India initiatives by the Prime
Project? the e-Hospital Project and the AIIMS Minister of India. The Digital AIIMS
The Digital AIIMS project, imple- Transformation Project. The online project, with nearly 45 lakh benefi-
mented as part of the Digital India registration software for AIIMS and ciaries, has had the highest footfalls
Initiative, has been widely termed as three other hospitals of Delhi was of Digital India Projects. AIIMS has
the First Digital Revolution in Health- launched on July 4, 2015 as part of been felicitated by the Ministry of
42 MARCH / 2017
ehealth.eletsonline.com
Leaders’ Perspective
Electronics & Information Technol- been implemented in a fragmented for digitizing services. How are
ogy for reaching the milestone of In- manner leading to little impact on the you going to do that?
dia’s First Fully Digital Public Hospi- institute activities. The Digital AIIMS The Prime Minister in his 2016 Inde-
tal. The Prime Minister commended project has envisaged and achieved pendence Day address commended
the Digital AIIMS project from the a major change in the management the Digital AIIMS project for replica-
ramparts of Red Fort in his August practices of the All India Institute of tion on a pan India basis. The Digi-
2016 Independence Day address. The Medical Sciences. It required crea- tal AIIMS project can benefit about
Ministry of Health and Family Wel- tion of specialised cadres in nursing, 3 crore patients if successfully repli-
fare has recommended the Project patient care, software professionals cated on pan India basis. AIIMS has
for the Prime Minister’s Award for and security personnel. The Nursing conducted several on-boarding work-
Excellence in Public Administration. Informatics Specialist cadre was cre- shops for Central Government Hospi-
As an official associated with the con- ated from within the existing nursing tals. A Hospital Transformation Cell
ceptualisation and implementation of personnel to coordinate between the has been constituted for handholding
the Digital AIIMS project from Jan- departments and the computer facil- state medical colleges and hospitals
uary 2015 till March 2017, I can say ity to ensure transparency in patient for creation of fully digital hospitals.
that the Digital AIIMS project can be management practices. The new and AIIMS has conducted an on-board-
termed equivalent to ‘Saving the Ti- follow-up appointments data are ing workshop for 42 medical institu-
tanic’ in creating a patient-friendly available on the Aadhar-enabled dig- tions of Kerala. Several state govern-
hospital at the apex medical sciences ital platform for easier patient man- ments have visited the Digital AIIMS
university of India. It has reduced pa- agement. The cadre of Data Entry project and a pan India replication
tient wait times by six hours per visit Operators has enabled speed in reg- process has commenced.
and freed up clinician’s OPD timings, istration at the OPD Counters. AIIMS
brought transparency and stream- used to have crowds waiting for the Do you have any proposal for
lined patient records. OPD registration from 3 am onwards. creating online registration fa-
Today, patients come at 8 am and the cilities for patients coming from
What is the role of specialised registration process is completed by other countries?
cadres in Digital AIIMS Project? 9.30 am. There are fast track regis- The online registration system en-
The e-Hospital project hitherto has tration counters also for those pa- ables patients to register from an-
tients who have made online registra- ywhere across the globe, with an
tions. The Patient Care Coordinators Aadhar-enabled number.
enable the patients to reach the cli-
nician’s OPD consultation rooms and What initiatives have you taken
allow follow up appointments. The for cashless payments in AIIMS?
Exit OPD counters have been created AIIMS has taken major steps for
to ensure that the next visit date of cashless payments through Internet
the Patient is available to him along banking, POS payments and other
with investigation dates. digital banking practices. Over 200
kiosks have been operationalised at
You have started OPD registra- AIIMS with Internet banking facil-
tion online. What are its advan- ities. Patients can make payments
tages and what is the system of through credit cards and other digi-
registering online? tal payment practices. The hospital
The online registration system was services worked seamlessly in coping
commenced in July 2015. Till date with the transition in the months of
the online registration has benefitted November - December 2016 post de-
45 lakh patients. The Aadhar linked monetisation.
online registration system enables
the patients to develop online OPD What are the challenges of
cards and has a linkage with Pay Gov Digital AIIMS Project?
portal for making patient payments. The replication of patient friendly
It is a huge step forward for creation hospitals requires sustained effort
of patient friendly hospitals and has and commitment. The Digital AIIMS
been replicated in all Central govern- project was successful because it
ment hospitals as also several state could bring together a large group of
government hospitals. individuals and ministries who could
V SRINIVAS function in synergy bringing their
Deputy Director, Administration AIIMS has been asked to assist collective positivity to make a major
AIIMS Hospitals in States across India systemic change.
MARCH / 2017
ehealth.eletsonline.com 43
Expert Opinion
Leveraging Technology
to Better Health Services
Always ready to adopt technological innovations to improve healthcare delivery,
Sir Ganga Ram Hospital in Delhi has added another feather to its cap by pioneering
the Smart OPD Solution by Mcura, thereby managing overcrowding at the hospital
and significantly reducing inconvenience to patients. Dr Ajay Swaroop Mathur,
Honorary Secretary cum Treasurer, Board of Management, Sir Ganga Ram Hospital,
in an interview with Vivek Ratnakar of Elets News Network, talks about his vision on
how technology has emerged as a big factor in improving health services.
What we are doing in telemedicine is restricted Will it also help patients in rural
areas?
to diagnosis of the health problem and providing Telemedicine is already a proven
method. Even the government is try-
appropriate advice to the local physician ing to reach rural areas to bridge
regarding the disease management. If a case the health delivery gap. It is a very
promising area and Sir Ganga Ram
is such that he or she needs to be referred Hospital already has a very active
to a better facility, then we provide whatever telemedicine programme, especially
in Himachal Pradesh.
treatment is required. What we are doing in telemedicine
is restricted to diagnosis of the health
44 MARCH / 2017
ehealth.eletsonline.com
Expert Opinion
MARCH / 2017
ehealth.eletsonline.com 45
healthsummit.eletsonline.com/karnataka
Host Partners Powered By Supported By
KARNATAKA
Bengaluru,
11th April, November
2017, 2016
Bengaluru
Transforming Healthcare
with Technology...
CONTACT US
For Programme Queries: Sudheer Goutham | sudhir@elets.in | +91-9966107831
For Partnership Queries: Nilender Kumar | nilender@elets.co.in | +91-8860635837
ehealth.eletsonline.com
......................................
Akhil Systems Pvt. Ltd.
your healthcare IT Partner
90
70
or
Juggling with data to analyze the Key Performance Indicators ?
AKHIL SYSTEMS
Brings Miracle- Management Information System
which will crunch all the complex data into
simple graphical representation with just one click
100%
08
07
10% 06
05
29% 29% 04
31% 03
02
01 0%
00
31%
30% 30% Fasten the
Make year to year, Get all the decision making
month to month and analysis at your and track all the
even day to day finger tips through hospital
comparison SMS and Email performance